Get the Stockscreener App
2.17
0.46%
0.010
After Hours:
2.15
-0.02
-0.92%
Seer Inc stock is traded at $2.17, with a volume of 121.15K.
It is up +0.46% in the last 24 hours and up +26.16% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$2.16
Open:
$2.15
24h Volume:
121.15K
Relative Volume:
0.16
Market Cap:
$119.31M
Revenue:
$15.04M
Net Income/Loss:
$-70.49M
P/E Ratio:
-1.7438
EPS:
-1.2444
Net Cash Flow:
$-49.88M
1W Performance:
+0.00%
1M Performance:
+26.16%
6M Performance:
+14.81%
1Y Performance:
+2.36%
1-Day Range:
$2.15
$2.175
1-Week Range:
$2.14
$2.19
52-Week Range:
$1.55
$2.41
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.17 | 118.76M | 15.04M | -70.49M | -49.88M | -1.2444 |
VRTX
Vertex Pharmaceuticals Inc
|
485.65 | 123.36B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.69 | 71.18B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
860.55 | 53.68B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
186.16 | 38.09B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
267.47 | 37.80B | 4.29B | 577.22M | 641.34M | 4.2086 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Seer (SEER) Faces Pressure for Board Changes as ISS Backs New Ca - GuruFocus
Radoff-JEC Group Announces ISS? Support of its Case for Change at Seer, Inc - marketscreener.com
[DFAN14A] Seer, Inc. SEC Filing - Stock Titan
Radoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc. - Stock Titan
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight - The Manila Times
Seer urges shareholders to vote for its board a... - Pluang
Seer (SEER) Proxy filing Summary - Quartr
Weekly Recap: Acquisition offer for Seer and shareholder vote on directors - TradingView
Seer Inc (SEER) Stock Forum and Discussion - Moomoo
Seer Inc Company Profile & Introduction - Moomoo
Seer director Nishar Dipchand sells $23,265 in Seer stock By Investing.com - Investing.com Australia
Form 4 Seer Inc For: 10 July By Investing.com - Investing.com Nigeria
Seer director Nishar Dipchand sells $23,265 in Seer stock - Investing.com
Seer, Inc. (SEER) director sells 10,660 shares in Rule 10b5-1 planned trade - Stock Titan
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction - AOL.com
The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of History - AOL.com
[144] Seer, Inc. SEC Filing - Stock Titan
Investors can join Seer, Inc. fraud investigati... - Pluang
SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer's Director Nominees - Investing News Network
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees - The Manila Times
The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today - AOL.com
CCORF Maintains Seer Inc(SEER.US) With Buy Rating, Maintains Target Price $4 - Moomoo
3 Penny Stocks With Market Caps Larger Than $80M - simplywall.st
SEER Q1 2026 Earnings: EPS Slightly Beats Estimates, Stock Surges Over 35%Earnings Yield Spread - dars.gov.et
Seer Shareholders Radoff, Torok Respond to CEO Omid Farokhzad's Acquisition Proposal - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Monday's session. - ChartMill
Radoff-JEC Group Urges Seer Shareholders to Back Independent Board Nominees - citybiz
NMAD Stock Price and Chart — NASDAQ:NMAD - TradingView
Monday's session: gap up and gap down stocks - ChartMill
Seer (SEER) Investors Call for Sale Amid Governance Concerns - GuruFocus
Seer Inc. Jumps On Buyout Bid As Activists Turn Up Heat - StocksToTrade
Seer Files Investor Presentation for Long-Term Value Creation Potential - marketscreener.com
Seer Issues Investor Presentation for Shareholders - marketscreener.com
The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.?s Proposal to Acquire Seer, Inc - marketscreener.com
Seer Inc. Stock Jumps As CEO Buyout Bid And Activists Collide - timothysykes.com
The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.'s Proposal to Acquire Seer, Inc. - Investing News Network
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential - Investing News Network
Radoff-Jec Group is actively urging shareholders of Seer, Inc. to vote in favor of three independent candidates—Berman, Horowitz, and Rinaldini—at the upcoming board election. - Bitget
Canaccord reiterates Seer stock rating on CEO buyout proposal - Investing.com
Canaccord reiterates Seer stock rating on CEO buyout proposal By Investing.com - Investing.com South Africa
These stocks are moving in today's pre-market session - ChartMill
Seer shares rally 30% following investor update ahead of annual meeting (SEER) - MSN
Seer Inc. (SEER) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc. - Stock Titan
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
2.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):